Literature DB >> 19534279

Encapsulated anaplastic thyroid carcinoma transformed from follicular carcinoma: a case report.

Amy Rapkiewicz1, Daniel Roses, Alec Goldenberg, Pascale Levine, Michael Bannan, Aylin Simsir.   

Abstract

BACKGROUND: Anaplastic thyroid carcinoma (ATC) is rare but is one of the most aggressive and lethal human malignancies. Cytologically, ATC has a variable morphologic appearance, including squamoid, giant, spindled and pleomorphic cells. The coexistence of ATC and differentiated or poorly differentiated thyroid carcinoma has been described and usually is diagnosed when the disease is locally advanced. CASE: We describe a case of surgically resectable, encapsulated, well-circumscribed ATC occurring in association with a better differentiated follicular carcinoma diagnosed by fine needle aspiration in a patient exposed to external ionizing radiation.
CONCLUSION: Encapsulated variants of anaplastic carcinoma can be seen in association with lower grade thyroid carcinoma such as follicular carcinoma. Accurate diagnosis is dependent on adequate sampling.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19534279     DOI: 10.1159/000325320

Source DB:  PubMed          Journal:  Acta Cytol        ISSN: 0001-5547            Impact factor:   2.319


  2 in total

1.  Coexisting well-differentiated and anaplastic thyroid carcinoma in the same primary resection specimen: immunophenotypic and genetic comparison of the two components in a consecutive series of 13 cases and a review of the literature.

Authors:  Moira Ragazzi; Federica Torricelli; Benedetta Donati; Alessia Ciarrocchi; Dario de Biase; Giovanni Tallini; Eleonora Zanetti; Alessandra Bisagni; Elisabetta Kuhn; Davide Giordano; Andrea Frasoldati; Simonetta Piana
Journal:  Virchows Arch       Date:  2020-07-18       Impact factor: 4.064

2.  NONINVASIVE ENCAPSULATED ANAPLASTIC THYROID CARCINOMA PROMISING AN EXCELLENT CLINICAL COURSE: A CASE REPORT AND REVIEW OF THE LITERATURE.

Authors:  F Dirilenoglu; A Kahraman Akkalp; H Bag; T Atasever Rezanko; Z Kucukodaci
Journal:  Acta Endocrinol (Buchar)       Date:  2018 Apr-Jun       Impact factor: 0.877

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.